Comparative Genomics of Disease and Carriage Serotype 1 Pneumococci.


Journal

Genome biology and evolution
ISSN: 1759-6653
Titre abrégé: Genome Biol Evol
Pays: England
ID NLM: 101509707

Informations de publication

Date de publication:
10 04 2022
Historique:
accepted: 12 04 2022
pubmed: 20 4 2022
medline: 12 10 2022
entrez: 19 4 2022
Statut: ppublish

Résumé

The isolation of Streptococcus pneumoniae serotypes in systemic tissues of patients with invasive disease versus the nasopharynx of healthy individuals with asymptomatic carriage varies widely. Some serotypes are hyper-invasive, particularly serotype 1, but the underlying genetics remain poorly understood due to the rarity of carriage isolates, reducing the power of comparison with invasive isolates. Here, we use a well-controlled genome-wide association study to search for genetic variation associated with invasiveness of serotype 1 pneumococci from a serotype 1 endemic setting in Africa. We found no consensus evidence that certain genomic variation is overrepresented among isolates from patients with invasive disease than asymptomatic carriage. Overall, the genomic variation explained negligible phenotypic variability, suggesting a minimal effect on the disease status. Furthermore, changes in lineage distribution were seen with lineages replacing each other over time, highlighting the importance of continued pathogen surveillance. Our findings suggest that the hyper-invasiveness is an intrinsic property of the serotype 1 strains, not specific for a "disease-associated" subpopulation disproportionately harboring unique genomic variation.

Identifiants

pubmed: 35439297
pii: 6570857
doi: 10.1093/gbe/evac052
pmc: PMC9048925
pii:
doi:

Substances chimiques

Pneumococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/P011284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R002592/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Society for Molecular Biology and Evolution.

Auteurs

Chrispin Chaguza (C)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Darwin College, University of Cambridge, Silver Street, Cambridge, UK.
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Chinelo Ebruke (C)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.

Madikay Senghore (M)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Department of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Stephanie W Lo (SW)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Peggy-Estelle Tientcheu (PE)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.

Rebecca A Gladstone (RA)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Department of Biostatistics, University of Oslo, Oslo, Norway.

Gerry Tonkin-Hill (G)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Jennifer E Cornick (JE)

Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Marie Yang (M)

Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Archibald Worwui (A)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.

Lesley McGee (L)

Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Robert F Breiman (RF)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Keith P Klugman (KP)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Aras Kadioglu (A)

Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Dean B Everett (DB)

College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.

Grant Mackenzie (G)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Murdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
London School of Hygiene & Tropical Medicine, London, UK.

Nicholas J Croucher (NJ)

MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.

Anna Roca (A)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
London School of Hygiene & Tropical Medicine, London, UK.

Brenda A Kwambana-Adams (BA)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection and Immunity, University College London, London, UK.

Martin Antonio (M)

Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
London School of Hygiene & Tropical Medicine, London, UK.
Warwick Medical School, University of Warwick, Coventry, UK.

Stephen D Bentley (SD)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH